Skip to content

Comparison of the Non-invasive Biobeat Device With an Invasive Arterial Line

Comparison of Continuous Blood Pressure Measurement Using the Non-invasive, Wireless Biobeat Monitor With an Invasive Arterial Line

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03603860
Enrollment
18
Registered
2018-07-27
Start date
2018-11-05
Completion date
2020-03-05
Last updated
2020-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure, Heart Diseases

Keywords

vital signs, blood pressure, cardiac surgery, non-invasive monitoring

Brief summary

In this clinical study the investigators will compare blood pressure measurements obtained using the non-invasive, continuous and wireless Biobeat monitoring device (a wrist watch or a patch configuration) to an invasive arterial line (radial or femoral) in 30 patients immediately after cardiac surgery, at the intensive care unit.

Detailed description

The Biobeat non-invasive, continuous and wireless monitoring device is based on photoplethysmograph technology. It measures several vital signs, including blood pressure, stroke volume, pulse rate, pulse pressure, heart rate variability, respiratory rate, saturation, cardiac output, cardiac index, and more. The data is transmitted to Biobeat's application (in both Apple and Google Play), and is available on the individual's cellular phone, tablet, or as a full monitoring system in a hospital department. The aim of this study is to compare the Biobeat monitor with the invasive method of blood pressure measurement, an arterial line. The study population includes 30 patients undergoing cardiac surgery. As per local protocol, each one of the participants will come out from the operating room with an arterial line. Once in the intensive care unit, the investigators will attach the Biobeat non-invasive monitor (either wrist watch or a patch, these two configurations are identical in terms of the monitoring system), and monitor the participants for 4 hours. Though both methods are continuous, the investigators will record the vital signs every 15 minutes during the 4 hours of the study.

Interventions

Comparing blood pressure measurement using the Biobeat non-invasive monitor to arterial line

Sponsors

The Baruch Padeh Medical Center, Poriya
CollaboratorOTHER_GOV
Biobeat Technologies Ltd.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients arriving immediately after cardiac surgery to the intensive care unit with an arterial line.

Exclusion criteria

* Refusal to participate * Patients with no arterial line * Pregnant women * Individuals under the age of 18 years * Patients with lack of judgment/mental illness * Patients working in the Baruch Padeh Medical Center

Design outcomes

Primary

MeasureTime frameDescription
Level of accordance between the Biobeat monitor and the arterial line4 hours per individualComparing blood pressure measurements of the Biobeat device with those of the arterial line. Both systolic blood pressure and diastolic blood pressure will be assessed during the study period.

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026